WHO vaccine-preventable diseases: monitoring system. 2013 global summary

Last updated 20-Octl-2013 (data as of 16-Oct-2013)
Next overall update June 2014
EPI mother and child logo         
Select a country

Development status: Developed economy GNI / capita (US$): 44'0101 Infant (under 12 months) mortality rate: 32
GDP / capita (US$): 40'3941 Child (under 5 years) mortality rate: 42

Population data in thousands3

  2012  2011  2010  2009  2008  2000  1990  1980 
Total population 82'800  82'893  83'017  83'183  83'380  83'512  80'487  79'169 
Births 699  697  696  696  698  768  842  827 
Surviving infants 697  695  694  694  696  765  836  817 
Pop. less than 5 years 3'451  3'442  3'458  3'479  3'512  3'989  4'442  4'076 
Pop. less than 15 years 10'913  11'012  11'133  11'279  11'437  13'036  12'938  14'659 
Female 15-49 years 18'416  18'686  18'936  19'176  19'385  20'078  19'686  19'508 

Number of reported case

(Click for retrospective incidence data for Germany)
Diphtheria 19 
Japanese encephalitis
Measles 166  1'607  780  574  917  28'745 
Mumps
Pertussis 258 
Polio*
Rubella
Rubella (CRS)
Tetanus (neonatal)
Tetanus (total) 18  21 
Yellow fever
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV);"
"it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Germany)
Vaccine year result method % card seen                                                
BCG         
DTP1         
DTP3          78  80 
HepB_BD         
HepB3          86  87  90  90  90  45 
Hib3          94  93  94  94  93  82 
JapEnc         
MCV          97  96  96  96  95  92  50 
MCV2          92  92  90  91  89 
PCV1         
PCV3          41  15 
Pol3          95  94  95  95  96  95  85 
Rota1         
Rota_last         
Rubella1          96  96  96  94  95 
TT2plus          80 
PAB         
VAD1         
YFV         
  ° indicates that more than 1 survey occurred that year

  Next update: July 2014

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Germany)
DTP1 97  97  97  97  97  96  93 
DTP3 93  93  93  93  93  90  80 
HepB3 86  86  86  86  86  84 
Hib3 94  94  94  94  94  94 
MCV 97  97  97  97  97  92  75  25 
PCV3 41  41  41  41  41 
Pol3 95  95  95  95  95  94  80  80 
Rota_last

Number of districts in the country 402  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90%
From 80 to 89%
From 50 to 79%
Less than 50%
Proportion of districts
not reporting DTP3 coverage
100
 

Immunization Schedule (2012 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
DTaP 2, 3, 4, 11-14 months;
DTaPHibHepIPV 2, 3, 4, 11-14 months; Yes
DTaPHibIPV 2, 3, 4, 11-14 months; Yes
HPV 12-17 years x3; Yes females
HepB 2, 4, 11-14 months; Yes
Influenza > 60 years; Yes
MMR 11-14, 15-23 months; Yes And adults born after 1970
MMRV 15-23 months; Yes
MenC_conj 11-14 months;
Pneumo_conj 2, 3, 4, 11-14 months; Yes
Pneumo_ps >60 years; Yes
TdPIPV 9-17 years; Yes with acellular pertussis
Tdap 5-6, 9-17 years; Yes
Varicella 11-14, 15-23 months; Yes

Immunizaton indicators

Indicator Expected answer 2012  2011  2010  2009  2008  2007  2006 

Planning and management

Multi-year plan (MYP) for immunization Yes/No/NR No  No  No  No  No  No  No 
What years does the MYP cover? number             NA 
Nº of districts with microplans that include activities to raise immunization coverage number              

National Immunization Advisory Mechanism

Does the country have a standing technical advisory group on immunization? Yes/No/NR Yes  Yes  Yes         

System performance

Total number of districts in country number 402  412  412  423  424  440  450 
Nº districts with DTP3 coverage >=80% number              
% of districts with DTP3 coverage >=80% From 0 to 100%              
Nº districts with measles (MCV1) coverage >=95% number              
% of districts with MCV1 coverage >=95% From 0 to 100%              

Safety

Monitoring of Adverse Events Following Immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
Does your country have a vaccine adverse events review committee? Yes/No/NR/ND Yes  Yes  No         

Finance

Percentage of routine vaccines funded by Government From 0 to 100%             5-10% (subnational level) 

Maternal and neonatal tetanus (NT) elimination

NT eliminated Yes/No Yes  Yes  Yes  Yes  Yes  Yes  Yes 

Sources

Unless otherwise specified, data provided by Member States through WHO-UNICEF Joint Reporting Form and WHO Regional offices.
 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2012, data for 2011
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.